HCC1954 TGL - Human Breast Cancer Cell


Species: Human

Category: Cancer

Tissue of Origin: Breast

Cancer Type: Ductal Breast Carcinoma 


HCC1954-TGL is a human breast cancer cell line.


This cell line was established from a breast metastasis in a 61 year old female with breast carcinoma

Lead Researcher/Research Laboratory

  • Joan Massague, PhD, Member and Laboratory Head, Cancer Biology & Genetics Program; Marie-Josee and Henry Kravis Foundation Chair; Director, Sloan-Ketteringn Institute, Memorial Sloan Kettering

Key References

PubMed=27015306; DOI=10.1016/j.cell.2016.02.025 Malladi S., Macalinao D.G., Jin X., He L., Basnet H., Zou Y., de Stanchina E., Massague J. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165:45-60(2016)


This cell line may be licensed nonexclusively for research or commercial purposes.

For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.

To proceed, please download this contract, fill in all relevant fields, and email a scanned version to TRMOTDRTM@mskcc.org. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.

For licensing requests for a commercial purpose:  Contact MSK’s Tangible Materials team at TRMOTDRTM@mskcc.org.

For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354weisgarf@mskcc.org

Stage of Development

Ready to use